|
1.
|
Percutaneous mitral valve repair in the initial EVEREST cohort: evidence of reverse left ventricular remodeling. MedStar authors:
Year: 2013
Citation: - Circulation. Cardiovascular imaging. 6(4):522-30, 2013 Jul.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - EVEREST Investigators, Fail PS, Feldman T, Foster E, Glower DD, Grayburn PA, Hermiller J, Herrmann HC, Kar S, Kwan D, Lim DS, Rinaldi MJ, Rogers JH, Schwartz A, Weissman NJ, Whitlow PL
|
|
2.
|
Treatment of Chronic Functional Mitral Valve Regurgitation With a Percutaneous Annuloplasty System. MedStar authors:
Year: 2016
Citation: - Journal of the American College of Cardiology. 67(25):2927-36, 2016 Jun 28
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abizaid A, Asch FM, Buszman P, Dager A, Demkow M, Ebner A, Hammerstingl C, Martinez Clark P, Nickenig G, Schueler R, Siminiak T
|
|
3.
|
5-Year Outcomes of Anterior Mitral Leaflet Laceration to Prevent Outflow Obstruction. MedStar authors:
Year: 2024
Citation: - Jacc: Cardiovascular Interventions. 17(18):2157-2167, 2024 Sep 23.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Clinical Trial
- Journal Article
- Multicenter Study
All authors: - Khan JM, Babaliaros VC, Greenbaum AB, McCabe JM, Rogers T, Eng MH, Foerst JR, Yazdani S, Paone G, Gleason PT, Halaby RN, Bruce CG, Tian X, Stine AM, Lederman RJ
|